Clinical Research Directory
Browse clinical research sites, groups, and studies.
Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease
Sponsor: University Hospital, Akershus
Summary
OBJECTIVES OF THE STUDY 1. Investigate whether there are just as few infusion reactions with infliximab infusions of 60 min and 30 min. 2. Investigate patient and nurse satisfaction with infusions of 60 min and 30 min. 3. Investigate resource use in terms of total length of stay and use of nursing resources.
Official title: IRAPID: Infliximab Infusion Rate in Pediatric Inflammatory Bowel Disease. a Randomized Non-inferiority Trial of Infusion Reactions with Infliximab Infusion-rates of 30 Minutes and 60 Minutes
Key Details
Gender
All
Age Range
1 Year - 18 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-02-01
Completion Date
2026-04
Last Updated
2025-02-27
Healthy Volunteers
No
Interventions
Infusion rate of infliximab
Infusion reactions of infliximab is compared between 30 and 60 minutes infliximab infusion-rates.
Locations (1)
Akershus University Hospital
Lørenskog, Norway